Skip to main content

Table 1 List of the primers used in the study

From: Blocking interleukin-23 ameliorates neuromuscular and thymic defects in myasthenia gravis

Gene

Forward

Reverse

Human

AID

AAGGGCTGCATGAAAATTCAGT

CGTCTCGTAAGTCATCAACCTC

Blimp1

AAGCAACTGGATGCGCTATGT

GGGATGGGCTTAATGGTGTAGAA

CXCL13

CTCTGCTTCTCATGCTGCTG

TGAGGGTCCACACACACAAT

GAPDH

CGACCACTTTGTCAAGCTCA

AGGGGTCTACATGGCAACTG

GM-CSF

TCCTGAACCTGAGTAGAGACAC

TGCTGCTTGTAGTGGCTGG

IFN-γ

TCCCATGGGTTGTGTGTTTA

AAGCACCAGGCATGAAATCT

IL-17A

CCCCTAGACTCAGGCTTCCT

AGTTCATTCTGCCCCATCAG

IL-6

TGAGGTGCCCATGCTACATTT

TCTGCGCAGCTTTAAGGAGTT

Keratin 14

TTCTGAACGAGATGCGTGAC

GCAGCTCAATCTCCAGGTTC

Ki67

AAGCCCTCCAGCTCCTAGTC

TCCGAAGCACCACTTCTTCT

Podoplanin

TGTGGCGCTTGGACTTTGT

GTGTAACAGGCATTCGCATCG

ST6gal1

TGCAGCCTCACGACAGATAC

ACCCTGAGAGACCTTCAGCA

Mouse

Aid

CCAGACTTTGGGTCGTGAAT

TGGCTTGTGATTGCTCAGAC

Cypa

CACCGTGTTCTTCGACATCAC

CCAGTGCTCAGAGCTCGAAAG

Gapdh

AACTTTGGCATTGTGGAAGG

ACACATTGGGGGTAGGAACA

Il-17a

TCTCTGATGTTGCTGCT

CGTGGAACGGTTGAGGTAGT

Il-6

AGTTGCCTTCTTGGGACTGA

TCCACGATTTCCCAGAGAAC

Il-6R

GACTATTTATGCTCCCTGAATGATCA

ACTCACAGATGGCGTTGACAAG

Il-21

GGACCCTTGTCTGTCTGGTAG

TGTGGACGTGATAGAAGTTCAGG

MyoD

AAGACGACTCTGACGGCTTG

TCTGGTGAGTCGAAACACGG

MyoG

GGGCAAACTCAGGAGCTTCT

CAGAGGCTTTGGAACCGGAT

Pax7

GGGCTCTTCAAGGTCTGGAC

CAGGGAGCAAGGAATGTGGA

Podoplanin

GCCAGTGTTGTTCTGGGTTT

AGAGGTGCCTTGCCAGTAGA

Sdf1

GCTCTGCATCAGTGACGGTA

ATTTCGGGTCAATGCACACT

St6gal1

CCTTATGCGGGCAATAGAAA

ACTTCCTATGCACCGTGGAC

Tgf-β1

CAAGGGCTACCATGCCAACT

CCGGGTTGTGTTGGTTGTAGA

Tgf-β3

GAGACCGGATAGCGAGTGGA

TTGGCCGCCTCTAACGATAT